EUVIMEDEUVIMED entdecken
Crossref

Young Onset Lung Cancer in India: Insights Into Clinical, Demographic, and Genomic Profiles

Prabhat Singh Malik, Neha Pathak, Aparna Sharma, Meghna Birla, Abhay Rastogi, Abha Sharma, Sachin Khurana, Deepam Pushpam, Ishaan Gupta, Amber Rathore, Deepali Jain, Sunil Kumar und 7 weitere

Clinical Lung Cancer · 2025

DOI: 10.1016/j.cllc.2025.02.014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Lung Cancer, 2025. Verfasst von Prabhat Singh Malik und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Dr.B.R.A.I.R.C.H., All India Institute of Medical Sciences, New Delhi, India. Electronic address: drprabhatsm@aiims.e…. Hauptthemen laut MEDLINE: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Biomarkers, Tumor. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Lung cancer (LC) is traditionally perceived as a disease primarily affecting the elderly. However, individuals under the age of 40 represent a rare subset, accounting for up to 6% of all LC cases. There is limited information about demographic, clinical, pathological, and molecular features and treatment outcomes of young-onset LC. METHODS: In this study, we have analyzed the clinical, pathological, molecular, treatment, and survival outcome data of non-small-cell lung cancer patients δ 40 years of age treated at a tertiary care center in India. Additionally, we compared the in-house genomic data of young-onset LC and late-onset LC tested on a common targeted next-generation sequencing (NGS) panel. RESULTS: A total of 133 patients were included, with a median age of 36 years (21-40 years). Females constituted 40.6% of total, and 79% were never smokers. Adenocarcinoma was the most common histology (85.7%), and oncogene fusions were common (ALK fusion in 34% and ROS1 in 7%). After a median follow-up of 39.2 months (95% CI 20.3-49.86), median overall survival was 26 months (95% CI 15.56-32.43) and median progression-free survival (of patients with stage 4 disease) was 6.53 months (95% CI 5.03-8.4). In-house NGS data reveals a striking enrichment of fusions (ALK and RET) in young-onset LC. CONCLUSION: Young-onset LC is a unique entity with a higher prevalence of targetable genomic alterations, especially oncogene fusions. All efforts should be made to identify the targetable alterations in this enriched population and implement targeted therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsCarcinoma, Non-Small-Cell LungBiomarkers, TumorHumansFemaleIndiaMaleAdultYoung AdultAge of OnsetGenomicsFollow-Up StudiesHigh-Throughput Nucleotide SequencingMiddle AgedPrognosisSurvival Rate

Stichwörter der Autor:innen

Driver mutationsGenomicsNon–small-cell lung cancerOncogene fusionTargeted therapy

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Medical Oncology, Dr.B.R.A.I.R.C.H., All India Institute of Medical Sciences, New Delhi, India. Electronic address: drprabhatsm@aiims.edu.
  • Department of Medical Oncology, Dr.B.R.A.I.R.C.H., All India Institute of Medical Sciences, New Delhi, India.
  • Department of Medical Oncology, National Cancer Institute (Jhajjar Campus), All India Institute of Medical Sciences, New Delhi, India.
  • Department of Biochemical Engineering and Biotechnology, Indian Institute of Technology, Delhi, India.
  • Department of Pathology, All India Institute of Medical Sciences, New Delhi, India.
  • Department of Surgical Oncology, Dr.B.R.A.I.R.C.H., All India Institute of Medical Sciences, New Delhi, India.

Zitieren

APA

Malik, P. S., Pathak, N., Sharma, A., Birla, M., Rastogi, A., Sharma, A., Khurana, S., Pushpam, D., Gupta, I., Rathore, A., Jain, D., Kumar, S., Pathy, S., Kaushal, R., Noronha, V., Prabhash, K., Karaba, A., Gauribidanur Raghavendrachar, V., & Muniyappa, N. (2025). Young Onset Lung Cancer in India: Insights Into Clinical, Demographic, and Genomic Profiles. Clinical Lung Cancer. https://doi.org/10.1016/j.cllc.2025.02.014

Vancouver

Malik PS, Pathak N, Sharma A, Birla M, Rastogi A, Sharma A, et al. Young Onset Lung Cancer in India: Insights Into Clinical, Demographic, and Genomic Profiles. Clinical Lung Cancer. 2025. doi:10.1016/j.cllc.2025.02.014

BibTeX
@article{Malik2025,
  author = {Malik, Prabhat Singh and Pathak, Neha and Sharma, Aparna and Birla, Meghna and Rastogi, Abhay and Sharma, Abha and Khurana, Sachin and Pushpam, Deepam and Gupta, Ishaan and Rathore, Amber and Jain, Deepali and Kumar, Sunil and Pathy, Sushmita and Kaushal, Rajiv and Noronha, Vanita and Prabhash, Kumar and Karaba, Aarati and Gauribidanur Raghavendrachar, Vijayshree and Muniyappa, Nagesh},
  title = {Young Onset Lung Cancer in India: Insights Into Clinical, Demographic, and Genomic Profiles},
  journal = {Clinical Lung Cancer},
  year = {2025},
  doi = {10.1016/j.cllc.2025.02.014}
}
Kostenlos starten →